{"meta":{"query_hash":"ca7bff41e2c0","filters":{"venue":"Issues in emerging health technologies"},"cohort_total":1,"direct_labels_cover":0,"predictions_cover":1,"exported":1,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/ca7bff41e2c0","api":"https://metacan.xera.ac/api/v1/cohort?venue=Issues+in+emerging+health+technologies"},"results":[{"id":"W3142001450","doi":"","title":"Do neuraminidase inhibitors prevent influenza","year":2001,"lang":"en","type":"article","venue":"Issues in emerging health technologies","topic":"Influenza Virus Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Neuraminidase; Zanamivir; Neuraminidase inhibitor; Medicine; Virology; Oseltamivir; Intensive care medicine; Pharmacology; Immunology; Internal medicine; Coronavirus disease 2019 (COVID-19); Virus; Disease; Infectious disease (medical specialty)","score_opus":0.09472881205207442,"score_gpt":0.46235137965589745,"score_spread":0.36762256760382306,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3142001450","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.50203884,0.33875906,0.0013761898,0.09715071,0.005805248,0.00021134182,0.001660757,0.000062723855,0.052935153],"genre_scores_gemma":[0.87527114,0.10323004,0.0011434045,0.011848024,0.0027813467,0.000053784082,0.0005532661,0.000013514979,0.0051055932],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.997426,0.0016209324,0.00020442401,0.0001412815,0.0003551657,0.00025220832],"domain_scores_gemma":[0.99030507,0.005978808,0.0017793167,0.0004759392,0.0010575645,0.0004032908],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0070095817,0.00022965162,0.00077094487,0.00037118405,0.00041240914,0.001102054,0.0006158759,0.0016988872,0.0050741457],"category_scores_gemma":[0.012624212,0.00018672255,0.0006665695,0.0005630307,0.0008765779,0.0015947828,0.00026455775,0.0012894744,0.0011859343],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.045759454,0.007309514,0.08598379,0.0060500386,0.0044762176,0.00039029564,0.00082310726,0.00056463026,0.012633171,0.015584907,0.039499063,0.7809258],"study_design_scores_gemma":[0.017995179,0.049596,0.340437,0.007086766,0.016143126,0.002188159,0.004522346,0.0012100653,0.07452997,0.027788088,0.4583612,0.00014207594],"about_ca_topic_score_codex":0.0024311047,"about_ca_topic_score_gemma":0.004801784,"teacher_disagreement_score":0.0070095817,"about_ca_system_score_codex":0.00089173275,"about_ca_system_score_gemma":0.0016442969,"threshold_uncertainty_score":0.037070632},"labels":[],"label_agreement":null}]}